Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAPPI
NCT07442357Recruiting
- Sponsor
- Rigshospitalet
- Start
- Oct 2026
- Primary completion
- Mar 2030
- Countries
- 2
01
Overview
Randomised, open-label trial in aortic valve stenosis (2 arms), sponsored by Rigshospitalet. Primary endpoint: Number of patients with a composite outcome of bacteremia or death at 6 months. Started Oct 2026; status: recruiting.
02
Conditions
aortic valve stenosis
Beyond the preview
Go deeper on NCT07442357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07442357.